Tocilizumab in severe COVID-19: A promise fulfilled. | Eur J Intern Med;95: 38-39, 2022 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Tocilizumab in severe COVID-19: A promise fulfilled.

Levi, Marcel.

Levi M; Amsterdam University Medical Center, Department of Vascular Medicine, , Amsterdam, the Netherlands; University College London Hospitals NHS Foundation Trust, Department of Medicine, UK; Cardiometabolic Programme-NIHR UCLH/UCL BRC, London, UK. Electronic address: m.m.levi@amsterdamumc.nl.

Eur J Intern Med ; 95: 38-39, 2022 01.

Article in English | MEDLINE | ID: covidwho-1525773

Subject(s)

COVID-19 Drug Treatment; Antibodies, Monoclonal, Humanized; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Eur J Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Eur J Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article